Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive intravenous tirofiban after successful endovascular thrombectomy in large vessel occlusion stroke (ADJUVANT-2)
ChiCTR2500106021Phase 4Recruiting
- Sponsor
- Xihua County People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirofiban in ischemic stroke (2 arms), sponsored by Xihua County People's Hospital. Primary endpoint: 90-day functional outcome (primary composite). Started Jul 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500106021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106021.